Abstract: The present disclosure includes systems and methods for configuring a radio base station of a cellular telecommunications network. An exemplary method includes receiving an instantaneous bandwidth (IBW) capability list from a radio unit that is coupled to an antenna and transmitting a control message to the radio unit to configure radio carriers for the radio unit. The control message is based on the IBW capability list. Associated network nodes are also included.

Abstract: Disclosed herein are technologies for providing recommendations as to particular products and/or services that are customer specific and general, based on customer preference and inquiry. The recommendations are provided as part of an online shopping system. In accordance with one aspect, an item query is received from a customer, and analyzed by a query analyzer to determine if the query is a general item query or a specific item query. A search may be performed for items based on the item query in an items database listing items offered for purchase. If the query is the general item query, customer preference is determined from results of the search. If the query is the specific item query, the items from the results of the search are grouped based on cost performance. The items of the search result are ranked and provided to the customer.

Abstract: This invention provides compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein T, J, R, R4, Rq, o, RA, W and RB and subsets thereof are as described in the specification. The compounds are inhibitors of NAMPT and are thus useful for treating cancer, inflammatory conditions, and/or T-cell mediated autoimmune disease.

Abstract: Disclosed herein are technologies for providing recommendations as to particular products and/or services that are customer specific and general, based on customer preference and inquiry. The recommendations are provided as part of an online shopping system. In accordance with one aspect, an item query is received from a customer, and analyzed by a query analyzer to determine if the query is a general item query or a specific item query. A search may be performed for items based on the item query in an items database listing items offered for purchase. If the query is the general item query, customer preference is determined from results of the search. If the query is the specific item query, the items from the results of the search are grouped based on cost performance. The items of the search result are ranked and provided to the customer.

Abstract: An evaporation source includes a casing, a crucible configured to receive evaporation material, a spray nozzle, a first heating wire, and a lifting mechanism. The casing includes a first end, a second end opposite the first end, and a transmission chamber disposed between the first end and the second end. The evaporation material forms a heating surface on a surface in the crucible when the evaporation material is heated in the crucible. The crucible is disposed in the casing and is positioned at the second end. The crucible is in communication with the transmission chamber. The spray nozzle is disposed at the first end and is in communication with the transmission chamber. The first heating wire is directly fixed in the casing and the first heating wire is positioned between the crucible and the spray nozzle. The lifting mechanism is movably connected to the casing.

Abstract: This invention provides compounds of formula I and subsets thereof: wherein T, J, R, R4, Rq, o, RA, and RB and subsets thereof are as described in the specification. The compounds are inhibitors of NAMPT and are thus useful for treating cancer, inflammatory conditions, or T-cell mediated autoimmune disease.

Abstract: Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.

Abstract: The present invention provides an OLED display element and an OLED display device. The OLED display element comprises a first electrode (2), an organic layer (3) and a second electrode (5) which are stacked from bottom to top in order, and a stabilizing layer (4) sandwiched between the second electrode (5) and the organic layer (3) or between the first electrode (2) and the organic layer (3); a material of the stabilizing layer (4) comprises a rare earth metal or a mixture of the rare earth metal and a mineral salt, which can maintain the stability of the electrode thin film and enhance the reliability of the OLED display element.

Abstract: This invention provides compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein T, J, R, R4, Rq, o, RA, W and RB and subsets thereof are as described in the specification. The compounds are inhibitors of NAMPT and are thus useful for treating cancer, inflammatory conditions, and/or T-cell mediated autoimmune disease.

Abstract: Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.

Abstract: Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.

Abstract: This invention provides compounds of formula I and subsets thereof: wherein T, J, R, R4, Rq, o, RA, and RB and subsets thereof are as described in the specification. The compounds are inhibitors of NAMPT and are thus useful for treating cancer, inflammatory conditions, or T-cell mediated autoimmune disease.

Abstract: A digital predistortion apparatus comprising: a nonlinear device; a memory effect compensator; a constant value characteristic acquirer; a cost function generator; and a coefficient updater is described.

Abstract: Disclosed herein are technologies for providing recommendations as to particular products and/or services that are customer specific and general, based on customer preference and inquiry. The recommendations are provided as part of an online shopping system. In accordance with one aspect, an item query is received from a customer, and analyzed by a query analyzer to determine if the query is a general item query or a specific item query. A search may be performed for items based on the item query in an items database listing items offered for purchase. If the query is the general item query, customer preference is determined from results of the search. If the query is the specific item query, the items from the results of the search are grouped based on cost performance. The items of the search result are ranked and provided to the customer.

Abstract: The invention relates to compounds represented by Structural Formula I, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates to a method of inhibiting a function of CCR9, and to the use compounds represented by Structural Formula I in research, therapeutic, prophylactic and diagnostic methods.

Abstract: Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.

Abstract: Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.

Abstract: This invention provides compounds of formula IA-i-a or IB-i-a and subsets thereof: wherein Z, HY, R1, R2, R3, G1, W, n, and A and subsets thereof are as described in the specification. The compounds are inhibitors of PI3K and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.

Abstract: This invention provides compounds of formula IA-a or IB-a and subsets thereof: wherein Z, HY, R1, R2, G1, W, n, and A and subsets thereof are as described in the specification. The compounds are inhibitors of PI3K and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.

Abstract: This invention provides compounds of formula IA or IB: wherein HY, R1, R2, G1, W, n, and A are as described in the specification. The compounds are inhibitors of PI3K and/or mTor and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.